Abstract
Summary An uncommon cause of dysuria Intravesical administration of Bacille-Calmette-Guerin (BCG) has become a mainstay of adjunctive therapy for superficial bladder cancer. We present the case of a 61-year-old male patient with dysuria six years after intravesical BCG immunotherapy as part of treatment for superficial bladder cancer. The patient developed further complications in addition to dysuria. We discuss the epidemi o logy and pathogenesis of this rare complication and the therapeutic options.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
Paper Title
Journal
Date
